Cerus Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Cerus wird ein Gewinn- und Umsatzwachstum von 47.5% bzw. 10.7% pro Jahr prognostiziert, während der Gewinn pro Aktie um 48.9% pro Jahr wachsen soll.

Wichtige Informationen

47.5%

Wachstumsrate der Gewinne

48.9%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum17.4%
Wachstumsrate der Einnahmen10.7%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert31 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Analysts Are Upgrading Cerus Corporation (NASDAQ:CERS) After Its Latest Results

Aug 04
Analysts Are Upgrading Cerus Corporation (NASDAQ:CERS) After Its Latest Results

The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 05
The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Recent updates

Cerus Corporation (NASDAQ:CERS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Sep 26
Cerus Corporation (NASDAQ:CERS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Analysts Are Upgrading Cerus Corporation (NASDAQ:CERS) After Its Latest Results

Aug 04
Analysts Are Upgrading Cerus Corporation (NASDAQ:CERS) After Its Latest Results

Cerus Corporation's (NASDAQ:CERS) 30% Jump Shows Its Popularity With Investors

Jul 18
Cerus Corporation's (NASDAQ:CERS) 30% Jump Shows Its Popularity With Investors

Does Cerus (NASDAQ:CERS) Have A Healthy Balance Sheet?

Jul 12
Does Cerus (NASDAQ:CERS) Have A Healthy Balance Sheet?

The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 05
The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Here's Why Cerus (NASDAQ:CERS) Can Afford Some Debt

Apr 12
Here's Why Cerus (NASDAQ:CERS) Can Afford Some Debt

Cerus Corporation (NASDAQ:CERS) Stock Rockets 29% But Many Are Still Ignoring The Company

Mar 07
Cerus Corporation (NASDAQ:CERS) Stock Rockets 29% But Many Are Still Ignoring The Company

Slammed 29% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

Jan 18
Slammed 29% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

Health Check: How Prudently Does Cerus (NASDAQ:CERS) Use Debt?

Oct 06
Health Check: How Prudently Does Cerus (NASDAQ:CERS) Use Debt?

Is Cerus (NASDAQ:CERS) A Risky Investment?

Jul 07
Is Cerus (NASDAQ:CERS) A Risky Investment?

Slammed 32% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

May 12
Slammed 32% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

Cerus: Technical Support Fades, Investment Case Weakens (Technical Analysis)

Sep 29

Cerus GAAP EPS of -$0.05 beats by $0.02, revenue of $47.63M beats by $4.87M

Aug 04

Cerus: Lacks Conviction Against Macro Backdrop, Technicals Supportive Of Near-Term Upside

Jul 14

Is Cerus (NASDAQ:CERS) Using Debt In A Risky Way?

Jul 06
Is Cerus (NASDAQ:CERS) Using Debt In A Risky Way?

Is Cerus (NASDAQ:CERS) Using Debt Sensibly?

Mar 17
Is Cerus (NASDAQ:CERS) Using Debt Sensibly?

Cerus Corporation: Outperforming And Gaining Momentum

Jan 28

Gewinn- und Umsatzwachstumsprognosen

NasdaqGM:CERS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2026225-4N/AN/A4
12/31/2025206-14N/AN/A5
12/31/2024186-21N/AN/A5
9/30/2024176-20-11-9N/A
6/30/2024170-24-27-23N/A
3/31/2024164-32-37-33N/A
12/31/2023156-37-48-43N/A
9/30/2023154-50-36-30N/A
6/30/2023153-51-25-21N/A
3/31/2023156-46-16-13N/A
12/31/2022162-43-28-26N/A
9/30/2022158-38-26-25N/A
6/30/2022154-42-30-30N/A
3/31/2022145-49-39-38N/A
12/31/2021131-54-35-34N/A
9/30/2021119-60-43-42N/A
6/30/2021107-61-41-40N/A
3/31/202197-61-41-39N/A
12/31/202092-60-43-42N/A
9/30/202085-62-43-41N/A
6/30/202079-66-62-58N/A
3/31/202076-69-70-63N/A
12/31/201975-71-74-65N/A
9/30/201970-71-73-64N/A
6/30/201968-67-55-47N/A
3/31/201965-62-48-43N/A
12/31/201861-58-32-31N/A
9/30/201861-53-35-34N/A
6/30/201856-52N/A-42N/A
3/31/201850-56N/A-46N/A
12/31/201744-61N/A-52N/A
9/30/201737-63N/A-52N/A
6/30/201737-64N/A-55N/A
3/31/201737-65N/A-57N/A
12/31/201637-63N/A-54N/A
9/30/201637-64N/A-53N/A
6/30/201635-65N/A-48N/A
3/31/201634-63N/A-48N/A
12/31/201534-56N/A-51N/A
9/30/201534-61N/A-51N/A
6/30/201536-56N/A-51N/A
3/31/201536-48N/A-46N/A
12/31/201436-39N/A-40N/A
9/30/201436-24N/A-38N/A
6/30/201436-34N/A-32N/A
3/31/201438-33N/A-28N/A
12/31/201340-43N/A-27N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CERS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: CERS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: CERS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: CERSDie Einnahmen des Unternehmens (10.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: CERSDie Einnahmen des Unternehmens (10.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CERS in 3 Jahren voraussichtlich hoch sein wird


Wachstumsunternehmen entdecken